Skip to main content
Clinical Trials/NCT07281807
NCT07281807
Not yet recruiting
Phase 4

Comparison of the Pain Levels of Single-Dose Premedication With Piroxicam and Prednisolone on Post-Endodontic Pain in Single-Visit Root Canal Treatment of Premolars

RANA AHMAD0 sites60 target enrollmentStarted: January 1, 2026Last updated:
Interventionspiroxicam 20mg

Overview

Phase
Phase 4
Status
Not yet recruiting
Sponsor
RANA AHMAD
Enrollment
60
Primary Endpoint
pain after single visit root canal treatment

Overview

Brief Summary

To compare the post operative mean pain scores by administering single-dose preoperative piroxicam and prednisolone in patients of irreversible pulpitis with symptomatic apical periodontitis.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy patient ranging between 18-40 years
  • Having at least one premolar with diagnosis of symptomatic irreversible pulpitis according to history, examination and radiographs.
  • Teeth having mature apex confirmed by periapical radiographs.

Exclusion Criteria

  • History of systemic disorders including HIV, Hepatitis
  • Pregnancy (As per Medical record/ Verbally)
  • Patient using medication such as analgesics or anti-inflammatory drugs
  • Patient allergic to lignocaine, piroxicam and prednisolone
  • Tooth not suitable for restoration
  • Periodontal probing depth ≥ 4mm
  • Retreatment cases
  • Patients having calcified canals assessed by radiographic findings

Arms & Interventions

Group A: piroxicam

Experimental

Group A: patients will be given piroxicam 20mg as premedication

Intervention: piroxicam 20mg (Drug)

Outcomes

Primary Outcomes

pain after single visit root canal treatment

Time Frame: 48 hours

pain score on visual analogue scale

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
RANA AHMAD
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

RANA AHMAD

Dr

Shaheed Zulfiqar Ali Bhutto Medical University

Similar Trials